RDD Pharma Appoints Michael Rice to Board of Directors

RDD Pharma, a specialty pharma company focused on innovative therapies for anorectal diseases and gastrointestinal disorders, today announced the appointment of Michael Rice to its Board of Directors, according to a PR Newswire press release.

Rice, founder of LifeSci Advisors, is a Founding Partner of LifeSci Advisors, a unique investor relations consultancy founded to provide companies in the life sciences a comprehensive solution to investor communications and outreach, and LifeSci Capital, a research-driven investment bank with deep domain expertise in the life sciences. 

Read the full press release here.